Kisqali User Reviews & Ratings (Page 2)
Kisqali has an average rating of 8.6 out of 10 from a total of 34 reviews on Drugs.com. 85% of reviewers reported a positive experience, while 3% reported a negative experience.
Reviews for Kisqali
- Pat...
- Taken for 6 months to 1 year
- September 27, 2020
For Breast Cancer, Metastatic "Been on Kisqali (ribociclib) since November 2019 and had minimum side effects. Tumor markers continue to drop. Will be having a PET scan soon. Will get back with results."
- Anonymous
- Taken for less than 1 month
- February 26, 2021
For Breast Cancer, Metastatic "With breast cancer metastasis, I am feeling very much better while using Kisqali. But I do have body pains, but that can be manageable. Now I can easily run my job and home affairs."
Frequently asked questions
- Does Kisqali improve survival / life expectancy for mBC?
- What are the benefits of taking Kisqali and Femara together?
- How do you take Kisqali?
- Car...
- Taken for 6 months to 1 year
- October 1, 2021
For Breast Cancer, Metastatic "Kisqali worked at first. All my numbers went down. Then they spiked up all at once."
- Sun...
- Taken for 1 to 6 months
- July 9, 2022
For Breast Cancer, Metastatic "Completed 5 rounds with no side effects, but now my bilirubin is a little high, so dosage decreased to 400 mg. Hoping and praying bilirubin goes down so I can keep taking this miracle drug."
Are you taking this medicine?
Your review helps others make informed decisions.- Ano...
- Taken for 6 months to 1 year
- May 12, 2025
For Breast Cancer, Metastatic "Diagnosed lobular MBC in Sept 2024. 6th cycle of Kisqali March 2025 PET scan showing NEAD March 2025. I am grateful for miracle medicines."
- Anonymous
- Taken for 6 months to 1 year
- July 18, 2024
For Breast Cancer, Metastatic "Very few side effects. Have been able to continue golf, pickleball, bridge, and a nice social life. 600 mg per day for 3 weeks, then one week off."
- Shi...
- Taken for 6 months to 1 year
- November 23, 2024
For Breast Cancer, Metastatic "It seems to be working, but after almost a year, I am getting some side effects. Nothing I can't handle, and I would rather have them than have the cancer spreading and growing."
- Muc...
- Taken for 1 to 6 months
- September 24, 2024
For Breast Cancer, Metastatic "In size. There are side effects: fatigue, reflux, constipation, heart rate disturbances (not sure if this is due to Kisqali or Letrozole). Hope it won't be worse, working, managing a social life."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Kisqali (ribociclib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
- En español
For Breast Cancer, Metastatic "I've completed 5 cycles of Kisqali with monthly injections of Faslodex and Zometa. Kisqali has been great with the only side effect being constipation."